GYRE THERAPEUTICS, INC. — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B2
424B3
424B4
424B5
425
8-A12G
8-K
8-K/A
ARS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFC14A
DEFM14A
DFAN14A
EFFECT
FWP
PRE 14A
PREC14A
PREM14A
PRER14A
PRRN14A
REGDEX
REGDEX/A
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3MEF
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K/A | 8-K/A | 0001193125-22-157739 | May 24, 2022 | May 19, 2022 |
| 8-K | 8-K | 0001193125-22-156879 | May 23, 2022 | May 19, 2022 |
| SC 13D/A | — | 0001171520-22-000299 | May 10, 2022 | — |
| DFAN14A | — | 0001171520-22-000300 | May 10, 2022 | — |
| PRRN14A | — | 0001171520-22-000290 | May 9, 2022 | — |
| 10-Q | 10-Q | 0001564590-22-018775 | May 9, 2022 | Mar 31, 2022 |
| 8-K | 8-K | 0001193125-22-144986 | May 9, 2022 | — |
| UPLOAD | — | 0000000000-22-004863 | May 4, 2022 | — |
| DFAN14A | — | 0001171520-22-000272 | May 2, 2022 | — |
| SC 13D/A | — | 0001171520-22-000271 | May 2, 2022 | — |
| 10-K/A | FORM 10-K/A | 0001193125-22-136435 | May 2, 2022 | Dec 31, 2021 |
| PREC14A | — | 0001171520-22-000258 | Apr 28, 2022 | — |
| SC 13D/A | — | 0001171520-22-000251 | Apr 21, 2022 | — |
| DFAN14A | — | 0001171520-22-000253 | Apr 21, 2022 | — |
| 8-K | 8-K | 0001193125-22-095321 | Apr 5, 2022 | Mar 31, 2022 |
| 10-K | 10-K | 0001564590-22-012877 | Mar 31, 2022 | Dec 31, 2021 |
| S-8 | S-8 | 0001193125-22-091897 | Mar 31, 2022 | — |
| DFAN14A | — | 0001171520-22-000196 | Mar 16, 2022 | — |
| 8-K | 8-K | 0001193125-22-076406 | Mar 16, 2022 | Mar 10, 2022 |
| SC 13D/A | — | 0001171520-22-000194 | Mar 16, 2022 | — |
| SC 13D/A | — | 0001171520-22-000185 | Mar 7, 2022 | — |
| DFAN14A | — | 0001171520-22-000187 | Mar 7, 2022 | — |
| SC 13G | — | 0000935836-22-000227 | Mar 4, 2022 | — |
| SC 13D/A | — | 0001171520-22-000167 | Feb 28, 2022 | — |
| DFAN14A | — | 0001171520-22-000169 | Feb 28, 2022 | — |
| DFAN14A | — | 0001171520-22-000148 | Feb 23, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-22-012156 | Feb 23, 2022 | Feb 11, 2022 |
| SC 13D/A | — | 0001171520-22-000147 | Feb 23, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-22-012159 | Feb 23, 2022 | Feb 11, 2022 |
| 8-K | 8-K | 0001193125-22-046614 | Feb 18, 2022 | Feb 16, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-010403 | Feb 16, 2022 | Feb 9, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-010407 | Feb 16, 2022 | Feb 9, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-010392 | Feb 16, 2022 | Feb 9, 2022 |
| SC 13G/A | — | 0000935836-22-000176 | Feb 14, 2022 | — |
| SC 13G/A | — | 0000935836-22-000109 | Feb 14, 2022 | — |
| SC 13G/A | SC 13G/A | 0001104659-22-021623 | Feb 14, 2022 | — |
| SC 13G | — | 0001037389-22-000212 | Feb 11, 2022 | — |
| SC 13G | SCHEDULE 13G | 0000947871-22-000195 | Feb 11, 2022 | — |
| SC 13D/A | SC 13D/A | 0001104659-22-008147 | Jan 27, 2022 | — |
| 8-K | 8-K | 0001193125-22-016551 | Jan 25, 2022 | — |
| SC 13G | — | 0001546007-22-000003 | Jan 18, 2022 | — |
| SC 13G | — | 0001546007-22-000002 | Jan 18, 2022 | — |
| 8-K | 8-K | 0001193125-22-007230 | Jan 12, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-22-002482 | Jan 7, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-22-002485 | Jan 7, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-22-002488 | Jan 7, 2022 | — |
| SC 13D/A | SCHEDULE 13D/A | 0001104659-22-001583 | Jan 5, 2022 | — |
| 10-Q | 10-Q | 0001564590-21-056450 | Nov 12, 2021 | Sep 30, 2021 |
| 8-K | 8-K | 0001193125-21-327327 | Nov 12, 2021 | — |
| SC 13D/A | SC 13D/A | 0001104659-21-129658 | Oct 26, 2021 | — |